Search results
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 6 days agoThe FDA has informed Moderna that it is working to conclude...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 1 day agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 6 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 8 hours agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 6 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 5 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 6 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Is This a Setback for Moderna?
Motley Fool via Yahoo Finance· 2 days agoSo, this isn't a setback for Moderna, and investors can breathe a sigh of relief. But it's still important to keep a close eye on the situation for one...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 3 days agoThe review is now expected to be completed by the end of this month. The FDA has, however, not...
